These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19149703)

  • 1. The proteomic approach in the development of prognostic biomarkers in atherothrombosis.
    Lorenzo O; Martín-Ventura JL; Blanco-Colio LM; Egido J; Tuñón J
    Recent Pat Cardiovasc Drug Discov; 2009 Jan; 4(1):25-30. PubMed ID: 19149703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic strategies in the search of new biomarkers in atherothrombosis.
    Tuñón J; Martín-Ventura JL; Blanco-Colio LM; Lorenzo O; López JA; Egido J
    J Am Coll Cardiol; 2010 May; 55(19):2009-16. PubMed ID: 20447523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deciphering acute coronary syndrome biomarkers: High-resolution proteomics in platelets, thrombi and microparticles.
    Navas-Carrillo D; Marín F; Valdés M; Orenes-Piñero E
    Crit Rev Clin Lab Sci; 2017 Jan; 54(1):49-58. PubMed ID: 28013562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quest for novel cardiovascular biomarkers by proteomic analysis.
    Vivanco F; Martín-Ventura JL; Duran MC; Barderas MG; Blanco-Colio L; Dardé VM; Mas S; Meilhac O; Michel JB; Tuñón J; Egido J
    J Proteome Res; 2005; 4(4):1181-91. PubMed ID: 16083268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics in atherothrombosis: a future perspective.
    Martín-Ventura JL; Blanco-Colio LM; Tunon J; Gomez-Guerrero C; Michel JB; Meilhac O; Egido J
    Expert Rev Proteomics; 2007 Apr; 4(2):249-60. PubMed ID: 17425460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atherothrombosis Prevention and Treatment with Anti-interleukin-1 Agents.
    Biondi-Zoccai G; Garmendia CM; Abbate A; Giordano A; Frati G; Sciarretta S; Antonazzo B; Versaci F
    Curr Atheroscler Rep; 2020 Jan; 22(1):4. PubMed ID: 31932973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic and metabolomic profiles in atherothrombotic vascular disease.
    Martinez-Pinna R; Barbas C; Blanco-Colio LM; Tunon J; Ramos-Mozo P; Lopez JA; Meilhac O; Michel JB; Egido J; Martin-Ventura JL
    Curr Atheroscler Rep; 2010 May; 12(3):202-8. PubMed ID: 20425260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics in atherosclerosis.
    Martinez-Pinna R; Martin-Ventura JL; Mas S; Blanco-Colio LM; Tuñon J; Egido J
    Curr Atheroscler Rep; 2008 Jun; 10(3):209-15. PubMed ID: 18489848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic Studies of Blood and Vascular Wall in Atherosclerosis.
    Stakhneva EM; Striukova EV; Ragino YI
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers of vulnerable atheromatous plaques: translational medicine perspectives.
    Wang X; Connolly TM
    Adv Clin Chem; 2010; 50():1-22. PubMed ID: 20521438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biology of atherosclerotic plaques: what we are learning from proteomic analysis.
    Blanco-Colio LM; Martín-Ventura JL; Vivanco F; Michel JB; Meilhac O; Egido J
    Cardiovasc Res; 2006 Oct; 72(1):18-29. PubMed ID: 16814757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predilection of Low Protein C-induced Spontaneous Atherothrombosis for the Right Coronary Sinus in Apolipoprotein E deficient mice.
    Heestermans M; Ouweneel AB; Hassan J; Kloosterman M; Reitsma PH; Gijbels MJJ; van Vlijmen BJM; van Eck M
    Sci Rep; 2018 Oct; 8(1):15106. PubMed ID: 30305662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil Extracellular Traps in Atherosclerosis and Atherothrombosis.
    Döring Y; Soehnlein O; Weber C
    Circ Res; 2017 Feb; 120(4):736-743. PubMed ID: 28209798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics and metabolomics in biomarker discovery for cardiovascular diseases: progress and potential.
    Tuñón J; Barbas C; Blanco-Colio L; Burillo E; Lorenzo Ó; Martín-Ventura JL; Más S; Rupérez FJ; Egido J
    Expert Rev Proteomics; 2016 Sep; 13(9):857-71. PubMed ID: 27459711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology and mechanisms of Acute Coronary Syndromes: atherothrombosis, immune-inflammation, and beyond.
    Cimmino G; Di Serafino L; Cirillo P
    Expert Rev Cardiovasc Ther; 2022 May; 20(5):351-362. PubMed ID: 35510629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue Factor and Atherothrombosis.
    Tatsumi K; Mackman N
    J Atheroscler Thromb; 2015; 22(6):543-9. PubMed ID: 26016513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The F11 receptor (F11R/JAM-A) in atherothrombosis: overexpression of F11R in atherosclerotic plaques.
    Babinska A; Azari BM; Salifu MO; Liu R; Jiang XC; Sobocka MB; Boo D; Al Khoury G; Deitch JS; Marmur JD; Ehrlich YH; Kornecki E
    Thromb Haemost; 2007 Feb; 97(2):272-81. PubMed ID: 17264957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New insights into the etiopathogenesis of atherosclerosis and atherothrombosis].
    Herman AG
    Bull Mem Acad R Med Belg; 2006; 161(3-4):213-25; discussion 226-7. PubMed ID: 17172227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma proteome profiling of atherosclerotic disease manifestations reveals elevated levels of the cytoskeletal protein vinculin.
    Kristensen LP; Larsen MR; Mickley H; Saaby L; Diederichsen AC; Lambrechtsen J; Rasmussen LM; Overgaard M
    J Proteomics; 2014 Apr; 101():141-53. PubMed ID: 24369271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS).
    Ridker PM; Thuren T; Zalewski A; Libby P
    Am Heart J; 2011 Oct; 162(4):597-605. PubMed ID: 21982649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.